Darla Granger, MD
Surgery · Detroit, MINPI 1700999083
Payments from drug & device makers
Across 18 payments — averaging $181.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$2K
- E.r. Squibb & Sons, L.L.C.$275
- Medtronic$240
- TELA Bio, Inc.$149
- Acera Surgical, Inc.$148
- Sanofi-aventis U.S. LLC$142
- plus $570 from 7 others
What the payments were for
- Consulting fees$1,75053%
- Food & beverage$1,52347%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shire North American Group Inc | 1 | $1,750 |
| E.r. Squibb & Sons, L.L.C. | 4 | $275 |
| Medtronic(2 entities) | 2 | $240 |
| TELA Bio, Inc. | 1 | $149 |
| Acera Surgical, Inc. | 1 | $148 |
| Sanofi-aventis U.S. LLC | 1 | $142 |
| Gilead | 2 | $128 |
| Vifor Pharma, Inc. | 1 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $113 |
| AstraZeneca | 1 | $107 |
| Philips North America LLC | 1 | $71 |
| Merck | 1 | $18 |
| Biomerieux Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NULOJIX$239
- INTERSTIM$170
- OviTex 2S$149
- Restrata Wound Matrix$148
- THYMOGLOBULIN$142
- Veltassa$118
- Epclusa$113
- LIVTENCITY$113
- ULTOMIRIS$107
How this compares
$3,273 in reported general payments places this provider in the 60th percentile of 1,081 surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 19 | $1,417 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 35 | $272 |
| Omeprazole | 17 | $203 |
| Prednisone | 13 | $174 |
| Atorvastatin Calcium | 15 | $119 |
| Nifedipine ErNifedipine | 14 | $98 |
| Famotidine | 15 | $61 |
Paid to pharmacies, not to this prescriber.
Other surgery in Detroit
- Amer AfanehDetroit$872K
- Marwan AbouljoudDetroit$446K
- Bellal JosephDetroit$348K
- Eliza BealDetroit$250K
- Arthur CarlinDetroit$177K
- Andrew HollenbeckDetroit$74K
- Jason RollsDetroit$51K
- Ozanan MeirelesLansing$2.3M
- Robert BartlettAnn Arbor$859K
- Matthew FourmanMonroe$492K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.